Patients who are seriously ill and have conversations with their clinicians about their values, goals, and wishes are more likely to have better outcomes, fewer non-beneficial medical interventions, and a better quality of life. Despite this, less than one third of seriously ill patients report discussing care goals and preferences with their clinicians. In this video, Rachelle Bernacki, MD, MS, of Ariadne Labs, talks about the development and evolution of the Serious Illness Care program. Designed around the Serious Illness Conversation Guide, the Serious Illness Care Program focuses on teaching clinicians how to talk to patients about what matters to them most. In this series of videos, Dr. Bernacki speaks about the core components of the program, the systems that need to be put in place to ensure these conversations happen reliably, the emerging evidence that supports the effectiveness of this program, and some of the surprises her team has encountered along the way.
What is the Serious Illness Care Program at Ariadne Labs?
How Does the Serious Illness Care Program Relate to the Work of Partners Population Health?
Evidence to Support the Effectiveness of the Serious Illness Care Program
Surprises in Developing the Serious Illness Care Program
Challenges in Implementing the Serious Illness Care Program
Advice for Implementing the Serious Care Illness Program
Scaling and Spreading the Serious Illness Care Program
For more information about the Serious Illness Care program, visit Ariadne Labs or read Effect of the Serious Illness Care Program in Outpatient Oncology in the March 14, 2019 issue of JAMA Internal Medicine.